CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CELZ · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
206
SEC Filings

Business Summary

Overview We are a commercial stage biotechnology company dedicated to the advancement regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Our platforms, therapies and products include the following: Our subsidiary, Creative Medical Technologies, Inc. (CMT), was originally created to monetize U.S. Patent No. 8,372,797 and related intellectual property related to the treatment of erectile dysfunction (ED), which it acquired in February 2016. Su...

Next Earnings

Q2 FY2026 — expected 2026-07-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCELZdiscussed_in_filing Artificial Intelligence
topic_mentionCELZdiscussed_in_filing Cybersecurity
topic_mentionCELZdiscussed_in_filing Trusted Computing
topic_mentionCELZdiscussed_in_filing Blockchain & Crypto
topic_mentionCELZdiscussed_in_filing Regulation
topic_mentionCELZdiscussed_in_filing Healthcare & Bio
topic_mentionCELZdiscussed_in_filing Platform & Ecosystem
topic_mentionCELZdiscussed_in_filing Artificial Intelligence
topic_mentionCELZdiscussed_in_filing Cybersecurity
topic_mentionCELZdiscussed_in_filing Trusted Computing
topic_mentionCELZdiscussed_in_filing Blockchain & Crypto
topic_mentionCELZdiscussed_in_filing Regulation
topic_mentionCELZdiscussed_in_filing Healthcare & Bio
topic_mentionCELZdiscussed_in_filing Platform & Ecosystem
topic_mentionCELZdiscussed_in_filing Artificial Intelligence
topic_mentionCELZdiscussed_in_filing Cybersecurity
topic_mentionCELZdiscussed_in_filing Trusted Computing
topic_mentionCELZdiscussed_in_filing Blockchain & Crypto
topic_mentionCELZdiscussed_in_filing Regulation
topic_mentionCELZdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-202025-12-310001477932-26-001517EDGAR43K words
2025-03-142024-12-310001477932-25-001736EDGAR—
2024-03-222023-12-310001477932-24-001431EDGAR—
2023-03-312022-12-310001477932-23-002123EDGAR—
2022-03-302021-12-310001477932-22-001741EDGAR—
2021-03-172020-12-310001477932-21-001495EDGAR—
2020-04-062019-12-310001104659-20-043660EDGAR—
2019-04-012018-12-310001144204-19-017462EDGAR—
2018-03-292017-12-310001144204-18-017967EDGAR—
2017-02-132016-12-310001144204-17-007873EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-072025-09-300001477932-25-007978EDGAR14K words
2025-08-082025-06-300001477932-25-005614EDGAR—
2025-05-092025-03-310001477932-25-003498EDGAR—
2024-11-082024-09-300001477932-24-006991EDGAR—
2024-08-092024-06-300001477932-24-004635EDGAR—
2024-05-102024-03-310001477932-24-002695EDGAR—
2023-11-142023-09-300001477932-23-008458EDGAR—
2023-08-112023-06-300001477932-23-005935EDGAR—
2023-05-122023-03-310001477932-23-003347EDGAR—
2022-11-102022-09-300001477932-22-008323EDGAR—
2022-08-122022-06-300001477932-22-005931EDGAR—
2022-05-132022-03-310001477932-22-003286EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-12-310001477932-25-009277EDGAR1K words
2025-12-190001477932-25-009094EDGAR—
2025-11-120001477932-25-008027EDGAR—
2025-10-310001477932-25-007849EDGAR—
2025-05-060001477932-25-003370EDGAR—
2025-04-110001477932-25-002645EDGAR—
2025-03-140001477932-25-001737EDGAR—
2025-03-070001477932-25-001537EDGAR—
2024-12-260001477932-24-008314EDGAR—
2024-10-230001477932-24-006644EDGAR—

206 total filings indexed. 174 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001187953
TickerCELZ
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 42d0d99c3ee842bd9ccec439e06630f979869cb3f6d45e0840202386b11d6dda
parent: 71c5669b70a1df122bc48765b666fe614aeda3188a6c0ad11a309b47c358c3d1
content hash: c2cce60e74c49e5a2a4600d0df7533e50fbfdad7acbbe6b683fc7df0f364b773
signed: 2026-04-13T04:44:16.291Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf